Professor Thomas Klopstock

Professor of Neurology at LMU Munich, Germany. Long-standing clinical and scientific expertise in mitochondrial and other neurogenetic disorders. Speaker of German network for mitochondrial disorders (mitoNET). Member of German Center for Neurodegenerative Diseases (DZNE), Munich Excellence Cluster for Systems Neurology (SyNergy), and board of directors of Munich Center for Rare Diseases (MZSE). Ample experience in clinical trials in neurogenetic diseases, including idebenone and gene therapy in LHON. Author of >350 publications. Main goal is contributing to disease-modifying treatments of mitochondrial diseases and other neurogenetic disorders.